GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Cyclically Adjusted Price-to-FCF

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Cyclically Adjusted Price-to-FCF : (As of Jun. 07, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Zhejiang Ausun Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.038/115.1156*115.1156
=-0.038

Current CPI (Mar. 2025) = 115.1156.

Zhejiang Ausun Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 99.000 0.000
201503 -0.044 99.900 -0.051
201512 0.000 100.600 0.000
201603 -0.050 102.200 -0.056
201606 0.005 101.400 0.006
201609 0.086 102.400 0.097
201612 0.046 102.600 0.052
201703 -0.010 103.200 -0.011
201706 0.002 103.100 0.002
201709 -0.027 104.100 -0.030
201712 0.029 104.500 0.032
201803 -0.012 105.300 -0.013
201806 -0.017 104.900 -0.019
201809 -0.013 106.600 -0.014
201812 -0.012 106.500 -0.013
201903 -0.008 107.700 -0.009
201906 0.016 107.700 0.017
201909 0.020 109.800 0.021
201912 0.025 111.200 0.026
202003 -0.023 112.300 -0.024
202006 0.047 110.400 0.049
202009 0.012 111.700 0.012
202012 0.012 111.500 0.012
202103 -0.116 112.662 -0.119
202106 0.109 111.769 0.112
202109 -0.077 112.215 -0.079
202112 -0.075 113.108 -0.076
202203 -0.146 114.335 -0.147
202206 -0.044 114.558 -0.044
202209 0.001 115.339 0.001
202212 0.027 115.116 0.027
202303 -0.024 115.116 -0.024
202306 0.007 114.558 0.007
202309 -0.094 115.339 -0.094
202312 0.189 114.781 0.190
202403 0.007 115.227 0.007
202406 -0.026 114.781 -0.026
202409 0.006 115.785 0.006
202412 0.091 114.893 0.091
202503 -0.038 115.116 -0.038

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Zhejiang Ausun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Ausun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
Executives
Zheng Zhi Guo Directors, senior managers
Zhang Hua Dong Directors, senior managers
Liu Bing Director

Zhejiang Ausun Pharmaceutical Co Headlines

No Headlines